These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28225148)

  • 21. Past hepatitis B virus infection was not associated with poorer response or the UK-PBC risk score in ursodeoxycholic acid-treated patients with primary biliary cirrhosis.
    Hu Z; Ni P; Fan X; Men R; Yang L
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):277. PubMed ID: 30575642
    [No Abstract]   [Full Text] [Related]  

  • 22. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC.
    Lazaridis KN; Larusso NF
    Gastroenterology; 2005 Feb; 128(2):498-500. PubMed ID: 15685560
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic fatigue should not be overlooked in primary biliary cholangitis.
    Shahini E; Ahmed F
    J Hepatol; 2021 Sep; 75(3):744-745. PubMed ID: 33640400
    [No Abstract]   [Full Text] [Related]  

  • 24. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
    Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V
    Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursodeoxycholic acid for primary biliary cirrhosis.
    Lindor KD; Poupon R; Poupon R; Heathcote EJ; Therneau T
    Lancet; 2000 Feb; 355(9204):657-8. PubMed ID: 10697011
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Vallone TM; Ditelberg J; Kaplan MM
    Dig Dis Sci; 2005 Jan; 50(1):167-70. PubMed ID: 15712656
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
    Floreani A; Franceschet I; Cazzagon N
    Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 31. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary biliary cholangitis, let's try to keep the new nomenclature correct!
    Harinck F
    Neth J Med; 2016 Jul; 74(6):229-30. PubMed ID: 27571719
    [No Abstract]   [Full Text] [Related]  

  • 33. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery.
    Monoe K; Takahashi A; Katsushima F; Kanno Y; Saito H; Abe K; Yokokawa J; Ohira H
    Intern Med; 2011; 50(12):1299-301. PubMed ID: 21673465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Talwalkar JA; Gossard AA
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.
    Koulentaki M; Moscandrea J; Dimoulios P; Chatzicostas C; Kouroumalis EA
    Dig Dis Sci; 2004 Aug; 49(7-8):1190-5. PubMed ID: 15387345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary biliary cirrhosis (PBC)].
    Rautiainen H
    Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment.
    March-Rodriguez A; Marcantonio O; Olmos-Alpiste F; Pujol RM
    Australas J Dermatol; 2022 Feb; 63(1):e49-e51. PubMed ID: 34905624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.